T. Gavan

发表

Laboratory Evaluation of a Rapid, Automated Susceptibility Testing System: Report of a Collaborative Study

A. Balows, J. Sherris, J. Washington, 1975, Antimicrobial Agents and Chemotherapy.

Infection due to methicillin-resistant Staphylococcus aureus. Report of an unusual case.

R. Farmer, C. M. Evarts, M. McHenry, 1969, Cleveland Clinic quarterly.

Rapid determination of minimum inhibitory concentrations of antimicrobial agents by the Autobac method: a collaborative study

J. Washington, C. Thornsberry, F. Schoenknecht, 1980, Antimicrobial Agents and Chemotherapy.

Pharmacokinetics of amikacin in patients with impaired renal function.

J. Wagner, D. Vidt, M. McHenry, 1976, The Journal of infectious diseases.

In vitro evaluation of cefixime (FK027, FR17027, CL284635): spectrum against recent clinical isolates, comparative antimicrobial activity, beta-lactamase stability, and preliminary susceptibility testing criteria.

L. Ayers, R. Jones, A. Barry, 1986, Diagnostic microbiology and infectious disease.

Standardization of disk diffusion and agar dilution susceptibility tests for Neisseria gonorrhoeae: interpretive criteria and quality control guidelines for ceftriaxone, penicillin, spectinomycin, and tetracycline

P. Murray, R. Jones, J. Washington, 1989, Journal of clinical microbiology.

Reproducibility of the analytab (API 20E) system

T. Gavan, D. A. Butler, C. M. Lobregat, 1975, Journal of clinical microbiology.

Familial late complement component (C6, C7) deficiency with chronic meningococcemia.

A. Weinstein, W. Braun, L. Calabrese, 1980, Archives of internal medicine.

Gentamicin dosages for renal insufficiency. Adjustments based on endogenous creatinine clearance and serum creatinine concentration.

J. Wagner, R. Gifford, M. McHenry, 1971, Annals of internal medicine.

A green function approach to the problem of two magnetic impurities in a non-magnetic metal

T. Gavan, B. Doman, 1969 .

Experimental myocardial infarction in the rat.

R. Hill, T. Gavan, N. Kaufman, 1959, A.M.A. archives of pathology.

Antibiotic concentrations in human bone

C. Nelson, M. Kolczun, M. McHenry, 1974 .

Cefuroxime, a New Parenteral Cephalosporin: Collaborative In Vitro Susceptibility Comparison with Cephalothin Against 5,887 Clinical Bacterial Isolates

Ronald N. Jones, A. Barry, P. Fuchs, 1977, Antimicrobial Agents and Chemotherapy.

Systemic absorption of neomycin irrigating solution.

A. Weinstein, M. McHenry, T. Gavan, 1977, JAMA.

Interpretive standards and quality control guidelines for imipenem susceptibility tests with 10-micrograms disks

R. Jones, A. Barry, C. Thornsberry, 1984, Journal of clinical microbiology.

Cefotetan, a new cephamycin: comparison of in vitro antimicrobial activity with other cephems, beta-lactamase stability, and preliminary recommendations for disk diffusion testing

L. Ayers, R. Jones, A. Barry, 1982, Antimicrobial Agents and Chemotherapy.

Ofloxacin susceptibility testing quality control parameters for microdilution and disk diffusion, and confirmation of disk diffusion interpretive criteria

R. Jones, A. Barry, P. Fuchs, 1989, Journal of clinical microbiology.

Selection of a reference lot of Mueller-Hinton agar

A. Barry, P. Fuchs, H. Frankel, 1986, Journal of clinical microbiology.

Unusual serum lipoprotein abnormality induced by the vehicle of miconazole.

A. Weinstein, R. Lederman, H. Naito, 1977, The New England journal of medicine.

Cefotaxime: in vitro activity and tentative interpretive standards for disk susceptibility testing

R. Jones, A. Barry, P. Fuchs, 1980, Antimicrobial Agents and Chemotherapy.

Quality control limits for ampicillin, carbenicillin, mezlocillin, and piperacillin disk diffusion susceptibility tests: a collaborative study

L. Reller, R. Jones, A. Barry, 1981, Journal of clinical microbiology.

3-0-demethyl fortimicin A: In vitro activity and interpretive zone standards for disk diffusion susceptibility tests

R. Jones, A. Barry, C. Thornsberry, 1984, European Journal of Clinical Microbiology.

Interpretation of the Disk Diffusion Susceptibility Test for Amikacin: Report of a Collaborative Study

J. Washington, P. Yu, C. Thornsberry, 1979, Antimicrobial Agents and Chemotherapy.

Evaluation of the Sensititre system for quantitative antimicrobial drug susceptibility testing: a collaborative study

R. Jones, A. Barry, T. Gavan, 1980, Antimicrobial Agents and Chemotherapy.

Evaluation of the Micro-Media System for Quantitative Antimicrobial Drug Susceptibility Testing: a Collaborative Study

R. Jones, A. Barry, T. Gavan, 1978, Antimicrobial Agents and Chemotherapy.

Azlocillin, a ureido penicillin active against Pseudomonas aeruginosa: interpretive zone standards and quality control parameters for tests with 75-mu g disks

R. Jones, A. Barry, C. Thornsberry, 1982, Journal of clinical microbiology.

RO 23-6240 (AM-833), a new fluoroquinolone: in vitro antimicrobial activity and tentative disk diffusion interpretive criteria.

L. Ayers, R. Jones, A. Barry, 1987, Diagnostic microbiology and infectious disease.

Evaluation of the MICUR system for quantitative antimicrobial susceptibility testing: a multiphasic comparison with reference methods

R. Jones, A. Barry, C. Thornsberry, 1982, Journal of clinical microbiology.

Moxalactam (LY127935), a new semisynthetic 1-oxa-beta-lactam antibiotic with remarkable antimicrobial activity: in vitro comparison with cefamandole and tobramycin

R. Jones, A. Barry, P. Fuchs, 1980, Antimicrobial Agents and Chemotherapy.

Quality control parameters and interpretive criteria for in vitro susceptibility tests with the macrolide azithromycin

A. Barry, C. Thornsberry, T. Gavan, 1989, European Journal of Clinical Microbiology and Infectious Diseases.

Evaluation of the Sceptor microdilution antibiotic susceptibility testing system: a collaborative investigation

R. Jones, A. Barry, C. Thornsberry, 1981, Journal of clinical microbiology.

Cefoperazone (T-1551), a new semisynthetic cephalosporin: comparison with cephalothin and gentamicin

R. Jones, A. Barry, P. Fuchs, 1980, Antimicrobial Agents and Chemotherapy.

Piperacillin (T-1220), a new semisynthetic penicillin: in vitro antimicrobial activity comparison with carbenicillin, ticarcillin, ampicillin, cephalothin, cefamandole and cefoxitin.

R. Jones, A. Barry, P. Fuchs, 1977, The Journal of antibiotics.

Gram-negative bacteremia of long duration. Clinical study of 29 patients.

W. Hawk, M. McHenry, T. Gavan, 1973, Cleveland Clinic quarterly.

Sensitivity, specificity, and reproducibility of the automicrobic system (with the Enterobacteriaceae-plus biochemical card) for identifying clinical isolates of Gram- negative bacilli

A. Barry, R. Badal, T. Gavan, 1982, Journal of clinical microbiology.

Clinical laboratory evaluation of automated microbial detection/identification system in analysis of clinical urine specimens

J. Washington, H. Isenberg, T. Gavan, 1979, Journal of clinical microbiology.

Multi-Laboratory Evaluation of an Automated Microbial Detection/Identification System

A. Balows, P. Smith, J. Washington, 1978, Journal of clinical microbiology.

Inter- and intralaboratory variability in antibiotic susceptibility tests with Pseudomonas aeruginosa and Enterobacteriaceae.

T. O'Brien, A. Barry, J. Matsen, 1976, The Journal of infectious diseases.

Ceftazidime, a pseudomonas-active cephalosporin: in-vitro antimicrobial activity evaluation including recommendations for disc diffusion susceptibility tests.

R. Jones, A. Barry, P. Fuchs, 1981, The Journal of antimicrobial chemotherapy.

Antimicrobial activity of Ro 15-8074, active metabolite of a new oral cephalosporin (Ro 15-8075), against 7,775 recent clinical isolates

L. Ayers, R. Jones, A. Barry, 1986, Antimicrobial Agents and Chemotherapy.

Evaluation of the sensititre microdilution antibiotic susceptibility system against recent clinical isolates: three-laboratory collaborative study

R. Jones, A. Barry, T. Gavan, 1980, Journal of clinical microbiology.

In vitro activity of mezlocillin and azlocillin compared with that of four other penicillins and two aminoglycosides.

R. Jones, A. Barry, C. Thornsberry, 1980, Cleveland Clinic quarterly.

In vitro evaluation of Augmentin by broth microdilution and disk diffusion susceptibility testing: regression analysis, tentative interpretive criteria, and quality control limits

A L Barry, R N Jones, T L Gavan, 1983, Antimicrobial Agents and Chemotherapy.

Cefoperazone disk diffusion susceptibility test: confirmation of the tentative interpretive criteria, Pseudomonas aeruginosa cross-resistance, and determination of quality control performance limits

R. Jones, A. Barry, D. Gibbs, 1982, Journal of clinical microbiology.

Cryptococcal meningitis causing fever of unknown origin in renal transplant recipients: report of two cases initially diagnosed by urine cultures.

W. F. Braun, A. Novick, M. McHenry, 1981, Transplantation.

Serum bactericidal testing with the Autobac system

J. Senturia, R. Smeby, T. Gavan, 1986, Journal of clinical microbiology.

Comparative study of three methods of identification of Enterobacteriaceae

L. Ayers, D. Taylor, T. Gavan, 1977, Journal of clinical microbiology.

Collaborative investigation of the AutoMicrobic System Enterobacteriaceae biochemical card

W. J. Martin, D. Rhoden, A. Balows, 1980, Journal of clinical microbiology.

Edwardsiella tarda--identification and clinical significance. Report of two cases.

T. Gavan, H. Chatty, 1968, Cleveland Clinic quarterly.

Fortimicin A: collaborative in vitro susceptibility. Comparison with amikacin and gentamicin against 11,840 clinical bacterial isolates

R. Jones, A. Barry, P. Fuchs, 1979, Antimicrobial Agents and Chemotherapy.

1-N-(S-3-amino-2-hydroxypropionyl) gentamicin B (Sch 21420): A collaborative in vitro susceptibility comparison with amikacin and gentamicin against 12,984 clinical bacterial isolates

Ronald N. Jones, A. Barry, P. Fuchs, 1978, Current Microbiology.

Ticarcillin: a collaborative in vitro comparison with carbenicillin against over 9,000 clinical bacterial isolates

R. Jones, A. Barry, P. Fuchs, 1977, The American journal of the medical sciences.

BL-S786, A NEW PARENTERAL CEPHALOSPORIN. I

Ronald N. Jones, A. Barry, P. Fuchs, 1977 .

Cefpiramide: comparative in-vitro activity and β-lactamase stability

Ronald N. Jones, L. Ayers, A. Barry, 1985 .

Cefaclor and cefatrizine, new investigational orally administered cephalosporins. In-vitro collaborative evaluation against clinical bacterial isolates and comparison with related antimicrobics.

R. Jones, A. Barry, P. Fuchs, 1979, American journal of clinical pathology.

Rosamicin: in vitro activity comparison with erythromycin and other antibiotics against clinical isolates from the genito-urinary tract and Neisseria meningitidis.

R. Jones, A. Barry, P. Fuchs, 1979, The Journal of antibiotics.

Disk diffusion testing, quality control guidelines, and antimicrobial spectrum of HR810, a fourth-generation cephalosporin, in clinical microbiology laboratories

L. Ayers, R. Jones, A. Barry, 1984, Journal of clinical microbiology.

Aztreonam: antibacterial activity, beta-lactamase stability, and interpretive standards and quality control guidelines for disk-diffusion susceptibility tests.

R. Jones, A. Barry, C. Thornsberry, 1985, Reviews of infectious diseases.

Evaluation of the MS-2 urine screening method for detection of bacteriuria

L. R. Mccarthy, T. Gavan, J. Robson, 1982, Journal of clinical microbiology.

A microdilution method for antibiotic susceptibility testing: an evaluation.

T. Gavan, M. Town, M. A. Town, 1970, American journal of clinical pathology.

In vitro antimicrobial susceptibility testing. Clinical implications and limitations.

T. Gavan, 1974, The Medical clinics of North America.

Antimicrobial activity and spectrum of cefoperazone against recent clinical isolates.

R. Jones, A. Barry, P. Fuchs, 1980, Clinical therapeutics.

Cefuroxime, an in vitro Comparison with Six Other Cephalosporins

R. Jones, A. Barry, P. Fuchs, 1977, Proceedings of the Royal Society of Medicine.

Meningitis due to Escherichia coli. Report of a case in a young adult treated with gentamicin.

M. McHenry, T. Gavan, D. Dohn, 1970, JAMA.

Quality control limits for teicoplanin susceptibility tests and confirmation of disk diffusion interpretive criteria

A L Barry, R N Jones, T L Gavan, 1987, Journal of clinical microbiology.

A note on the correlation between the spins of the conduction electrons and that of a localised magnetic moment

T. Gavan, B. Doman, 1969 .

Quality control limits for microdilution susceptibility tests with aztreonam, imipenem, ceftriaxone, ceftazidime, ceftizoxime, cefuroxime, and cefonicid.

L. Ayers, R. Jones, A. Barry, 1987, Diagnostic microbiology and infectious disease.

In vitro activity of carumonam (RO 17-2301), BMY-28142, aztreonam, and ceftazidime against 7,620 consecutive clinical bacterial isolates.

L. Ayers, R. Jones, A. Barry, 1986, Diagnostic microbiology and infectious disease.

Interpretive criteria and tentative quality control limits for apalcillin disk susceptibility tests

R. Jones, A. Barry, C. Thornsberry, 1984, Journal of clinical microbiology.

Quality control limits for microdilution susceptibility tests with norfloxacin

L. Ayers, A. Barry, P. Fuchs, 1987, Journal of clinical microbiology.

Therapy with gentamicin for bacteremic infections: results with 53 patients.

W. Hawk, M. McHenry, T. Gavan, 1971, The Journal of infectious diseases.

Antimicrobial activity of Ro 19-5247 (T-2525), a new oral cephalosporin, tested against 7,745 recent clinical isolates.

L. Ayers, R. Jones, A. Barry, 1987, Diagnostic microbiology and infectious disease.

The effects of prolonged hypothermia on the rat.

R. Hill, T. Gavan, N. Kaufman, 1958, A.M.A. archives of pathology.

BL-S786, a new parenteral cephalosporin. I. A collaborative in vitro susceptibility comparison to cephalothin against 5,762 clinical bacterial isolates.

R. Jones, A. Barry, P. Fuchs, 1977, The Journal of antibiotics.

Interpretive criteria, quality control guidelines, and drug stability studies for susceptibility testing of cefotaxime, cefoxitin, ceftazidime, and cefuroxime against Neisseria gonorrhoeae.

P. Murray, R. Jones, J. Washington, 1990, Diagnostic microbiology and infectious disease.

Standardization ofDiskDiffusion andAgarDilution Susceptibility Tests forNeisseria gonorrhoeae: Interpretive Criteria andQuality Control Guidelines forCeftriaxone, Penicillin, Spectinomycin, andTetracycline

Ronald N. Jones, E. Gerlach, T. Gavan, 1989 .

The laboratory microbiologist in clinical medicine.

T. Gavan, 1978, Annals of internal medicine.

Effects of Blood on Blood Culture Medium

K. Beaman, T. Gavan, B. Kasten, 1979, Journal of clinical microbiology.

The culture of sterile urine for detection of anaerobic bacteria--not necessary for standard evaluation.

T. Gavan, A. Kuklinca, 1969, Cleveland Clinic quarterly.

Pharmacokinetics of gentamicin during exchange transfusions in neonates.

A. Fanaroff, R. Kliegman, J. Bertino, 1980, The Journal of pediatrics.

In vitro activity of apalcillin compared with those of piperacillin and carbenicillin against 6,797 bacterial isolates from four separate medical centers

L. Ayers, R. Jones, A. Barry, 1984, Antimicrobial Agents and Chemotherapy.

Ticarcillin, carbenicillin and BL-P1908. In vitro comparison of three anti-pseudomonal semisynthetic penicillins.

R. Jones, A. Barry, P. Fuchs, 1977, The Journal of antibiotics.

Antibiotic concentrations in human bone. A preliminary report.

C. Nelson, M. Kolczun, M. McHenry, 1974, Journal of Bone and Joint Surgery. American volume.

Accuracy and precision of the autobac system for rapid identification of Gram-negative bacilli: a collaborative evaluation

B. Sielaff, P. Smith, A. Barry, 1982, Journal of clinical microbiology.

Accuracy andPrecision oftheAutobac System forRapid Identification ofGram-Negative Bacilli: aCollaborative Evaluation

P. Smith, A. Barry, J. Matsen, 1982 .

Experimental renal infarction. II. Histochemical, fatty, and morphologic changes.

T. Gavan, N. Kaufman, 1956, A.M.A. archives of pathology.

A summary of the bacteriology portion of the 1972 basic, comprehensive, and special, College of American Pathologists (CAP) Quality Evaluation Program.

T. Gavan, 1974, American journal of clinical pathology.

An evaluation of the microbiology portions of the 1969 basic, comprehensive, and special College of American Pathologists proficiency testing surveys.

T. Gavan, J. W. King, 1970, American journal of clinical pathology.

Anaerobic bacteria in postmortem blood cultures. Correlation with lesions of the gastrointestinal tract.

T. Gavan, A. Kuklinca, 1971, Cleveland Clinic quarterly.